The previous page is sending you to https://medically.gene.com/content/dam/pdmahub/restricted/oncology/ispor-2021/ISPOR-2021-poster-lin-cost-effectiveness-of-atezolizumab-monotherapy-versus-pembrolizumab-monotherapy-for-first-line-treatment-of-metastatic-non-small-cell-lung-cancer.pdf.

 If you do not want to visit that page, you can return to the previous page.